Study of eye treatment for cancer that has spread to the eye
Part of Cancer, Eyes & vision clinical trials.
This trial tests a new way to treat cancer that has spread to the back of the eye (choroid). The treatment is given directly into the eye, which may help control the tumor and preserve vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer that has spread to the eye (choroid), and the diagnosis of the primary cancer has been confirmed.
- You have at least one area of cancer in the back of the eye in the study eye.
- You do not have an active eye infection or other eye disease.
- You do not have a tumor in the brain that needs radiation therapy that might affect the study eye.
- You are not planning to start or change your overall cancer treatment (like chemotherapy or immunotherapy) during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies ways to prevent worsening vision caused by radiation damage to the retina after plaque brachytherapy for uveal melanoma. You may be randomly assigned to a medication injection, a steroid implant, or observation to see which approach best protects vision.
This study follows people who finished a previous trial for a type of eye cancer called early choroidal melanoma. It checks how patients are doing over time after receiving either the study treatment (bel-sar) or a placebo (sham).
This trial studies giving chemotherapy directly into the spinal fluid to treat retinoblastoma that has spread to the central nervous system (brain/spinal cord). It may help by targeting tumor cells that are in the fluid around the brain and spinal cord.
This Phase 2 study tests a way to deliver cancer treatment directly inside the eye to treat retinoblastoma. It may help shrink the tumor while limiting treatment to the eye when possible.
This early-phase study tests whether melphalan can be used to reduce (shrink) a type of eye cancer called choroidal melanoma before additional treatment. It may help by controlling tumor size while doctors closely monitor the eye and outcomes.
This study collects information and eye health data from people who have had cancer treatment, including stem cell transplants. It helps doctors understand how cancer therapies affect the eyes over time.
Hear when a new Eye Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.